|Videos|May 20, 2017

The Risks and Benefits of Prescribing Antibiotics

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the importance of preserving the effectiveness of antibiotics.

Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the importance of preserving the effectiveness of antibiotics.

Interview Transcript (slightly modified for readability)

“One thing that I think is really important, no matter who the prescriber is, is that the prescriber think about the risks and benefits of prescribing that antibiotic. For many, many years, we’ve thought of antibiotics as the quick-fix to, pretty much, any infection. What we’ve learned, over the years, is that there are actual severe consequences associated with treating antibiotics without respect.

What I’m proposing is that we really need to be taking antibiotic treatment more seriously. When we talk to our patients about antibiotics we need to really be communicating about both the risks and benefits of antibiotics.

I like to think of antibiotics as a natural resource that is in limited supply. We really should be thinking about opportunities to preserve the effectiveness of these life-saving drugs, so that when our children need them, when our parents need them, for serious infections, that they will actually work.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.